References
- Abbas Ael-S, Deschamps C. Postpneumonectomy empyema. Curr Opin Pulmonary Med 2002; 8: 327–33.
- Massard G, Lyons G, Wihlm JM, et al. Early and longterm results after completion pneumonectomy. Ann Thorac Surg 1995; 59: 196–200.
- Athanassiadi K, Vassilikos K, Misthos P, et al. Late postpneumonectomy bronchopleural fistula. Thorac Cardiovac Surg 2004; 52: 298–301.
- Schneiter D, Cassina P, Korom S, et al. Accelerated treatment for early and late postpneumonectomy empyema. Ann Thorac Surg 2001; 72: 1668–72.
- Wain JC. Management of late postpneumonectomy empyema and bronchopleural fistula. Chest Surg Clinic 1996; 6: 529–41.
- Hollaus PH, Huber M, Lax F, Wurnig P, Bohm G, Pridun NS. Closure of bronchopleural fistula after pneumonec-tomy with a pedicled intercostal muscle flap. Eur J Cardio-tho-rac Surg 1999; 16: 181–6.
- Jadczuck E. Postpneumonectomy empyema. Eur J Cardio-thorac Surg 1998; 14: 123–6.
- Gharagozloo F, Trachiotis G, Wolfe A, Dubree KJ, Cox JL. Pleural space irrigation and modified Clagett procedure for the treatment of early postpneumonectomy empyema. J Thorac Cardiovasc Surg 1998; 116: 943–8.
- Kacprzak G, Marciniak M, Addae-Boateng E, Kolodziej J, Pawelczyk K. Causes and management of postpneumonec-tomy empyemas: our experience. Eur J Cardio-thorac Surg 2004; 26: 498–502.
- Miller JD, Nemni J, Simone C, Young JE, Bennett WF, Urschel JD. Prophylactic intracavitary (pneumonectomy space) antibiotic instillation: a comparative study. Ann Thorac Cardiovasc Surg 2001; 7: 14–6.
- Whitby M. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus. Intern J Antimicrob Agents 1999; 12 (Suppl 2):567–571.
- Collignon P, Turnidge J. Fusidic acid in vitro activity. Intern J Antimicrob Agents 1999; 12 (Suppl 2):545–558.
- Leclercq R, Bismuth R, Casin I, et al. In vitro activity of fusidic acid against streptococci isolated from skin and soft tis-sue infections. J Antimicrob Chemother 2000; 45: 27–9.
- Whitby M. Fusidic acid in septicemia and endocarditis. Intern J Antimicrob Agents 1999; 12 (Suppl 2):517–522.
- American Joint Committee on Cancer. Staging of can-cer forms. 3rd ed. New York: JB Lippincott 1988.
- Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Color Atlas and Textbook of Diagnostic Microbiology, 5th Ed. Philadelphia: Lippincott, 1997.
- National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk sus- ceptibility tests. Approved standard M2-A7. Wayne,: NCCLS, 2001.
- Juhl B, Frost N. A comparison between measured and calculated changes in the lung function after operation for pul-monary cancer. Acta Anaesthesiol Scand 1975; 57(Suppl):39-45.
- Garrett ER, Richard AJ. Kinetics and mechanisms of drug action on microorganisms XX. Integrated receptor site model rationalizing observed microbial rate dependencies on drug concentration and microbial kinetics affected by sodium fusidate. J Pharm Sci 1974; 63: 884–94.
- Turnidge J. Fusidic acid pharmacology, pharmacokinet-ics and pharmacodynamics. Intern J Antimicrob Agents 1999; 12(Suppl 2):523–534.
- Kentall SW, Antrum RM, Ramsden CH, Kester RC. A study of fucidin uptake in ischaemic tissues. Drugs Exp Clin Res 1988; 14: 655–7.
- de Louvois J, Hurley R. Inactivation of penicillin by purulent exudates. Br Med J 1977; 1 (6067): 998–1000.
- Morris SD, Rycroft RJ, White IR, Wakelin SH, McFadden JP. Comparative frequency of positive allergic patch test reactions to topical antibiotics. Br J Dermatol 2002; 146: 1047–51.
- Christiansen K. Fusidic acid adverse drug reactions. Intern J Antimicrob Agents 1999; 12(Suppl 2):53–59.
- Nagaev I, Bjorkman J, Andersson DI, Hughes D. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol 2001; 40: 433–9.